Relation Between Interleukin-6, Interleukin-10 And Interleukin-2 Receptor And Mortality In Severely Ill COVID-19 Patients

To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Pakistan Medical Association Vol. 73(Suppl 4); no. 4; pp. S179 - S183
Main Authors Hassan, Asmaa Embarak, Nosair, Nahla Abdelaziz, Ahmed, Mohammed Hussien, Sherif, Dalia Elsayed, Habib, Eman Mohammad, Farahat, Nahla
Format Journal Article
LanguageEnglish
Published Pakistan Pakistan Medical Association 01.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25. Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysisidentified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05). Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients.
AbstractList To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25. Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysisidentified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05). Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients.
Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. Methods: This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25 Results: Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysis identified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05). Conclusion: Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients. Keywords: Interleukin-6, Interleukin-10, Procalcitonin, Fibrin fragment D, COVID-19, Luminescence, Interleukin-2, Immunoassay, Fibrinogen, Ferritins
ObjectivesTo investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. MethodThis single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25. RESULTSOf the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysisidentified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05). CONCLUSIONSElevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients.
Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection.Methods: This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25Results: Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysis identified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatoryand coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05).Conclusion: Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients.Keywords: Interleukin-6, Interleukin-10, Procalcitonin, Fibrin fragment D, COVID-19, Luminescence, Interleukin-2, Immunoassay, Fibrinogen, Ferritins
Author Sherif, Dalia Elsayed
Hassan, Asmaa Embarak
Nosair, Nahla Abdelaziz
Habib, Eman Mohammad
Farahat, Nahla
Ahmed, Mohammed Hussien
Author_xml – sequence: 1
  givenname: Asmaa Embarak
  surname: Hassan
  fullname: Hassan, Asmaa Embarak
  organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt
– sequence: 2
  givenname: Nahla Abdelaziz
  surname: Nosair
  fullname: Nosair, Nahla Abdelaziz
  organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt
– sequence: 3
  givenname: Mohammed Hussien
  surname: Ahmed
  fullname: Ahmed, Mohammed Hussien
  organization: Department of Internal Medicineand Gastroenterology, Kafrelsheikh University,Egypt
– sequence: 4
  givenname: Dalia Elsayed
  surname: Sherif
  fullname: Sherif, Dalia Elsayed
  organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt
– sequence: 5
  givenname: Eman Mohammad
  surname: Habib
  fullname: Habib, Eman Mohammad
  organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt
– sequence: 6
  givenname: Nahla
  surname: Farahat
  fullname: Farahat, Nahla
  organization: Department of Clinical Pathology, Alexandria University, Alexandria,Egypt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37482854$$D View this record in MEDLINE/PubMed
BookMark eNpVUU1PGzEQ9YGKr3LurdpjD13w966PacpHEAhE2ko9Wd71GC04dmo7oPx7loQicZqZN2_ek-YdoJ0QAyD0heBj3jBFTi5vryfHp-d_6zmvmdxB-xgzXCvV0j10kPMDxlQKjHfRHmt4S1vB99H6DrwpQwzVDyjPAKGahQLJw-pxCLX8_mEkuJoE-wGi1R30sCwxbVbXMRXjh7IeSdUcniCBH3vvq-nNn9nPmqjqdrSDUPJn9MkZn-HorR6i32env6YX9dXN-Ww6uap7JlmpDZMWrOtBOWaFwYD71incSGVF04CVje065YwVinXgeNNTKZWwSmFMKLPsEM22ujaaB71Mw8KktY5m0BsgpnttUhl6D5oqSnhHO2Gs5I4SJUYXx5kZXyU6Tkatb1utZYr_VpCLXgy5B-9NgLjKmraccEyZkiP1ZEvtU8w5gXu3Jlhv8tKveekxLz3nmr1efH0TX3ULsO_8_2GxFzwflCE
CitedBy_id crossref_primary_10_58742_bmj_v2i2_96
ContentType Journal Article
DBID NPM
AAYXX
CITATION
7X8
DOA
DOI 10.47391/JPMA.EGY-S4-36
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage S183
ExternalDocumentID oai_doaj_org_article_29214b2b5ad64f219569df43a8545b41
10_47391_JPMA_EGY_S4_36
37482854
Genre Journal Article
GroupedDBID ---
.55
0ZK
2WC
53G
5GY
ABCQX
ABUBX
ACGFO
ACMJI
ADCHZ
ADEYR
AEGXH
AENEX
AFJDA
AGFXM
AGQRV
AHEHV
AHHXF
AHKOF
AIAGR
AKNUK
ALMA_UNASSIGNED_HOLDINGS
BAI
BAW
DIK
E3Z
EBD
EMOBN
EOJEC
F5P
FRP
GROUPED_DOAJ
GX1
IAO
IEA
IHR
IHW
INH
INR
ITC
L7B
LGEZI
LOTEE
LXO
MK0
MV.
NADUK
NFBOU
NKUNM
NPM
NXXTH
NYMDV
OBODZ
OK1
P2P
PV9
RXW
RZL
SV3
TAA
TUS
UNMZH
USXSC
W2D
X7M
~ZZ
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c363t-a36dedfce9f3d5a0e0c8f90769d577ed67dbb9fad593bef47c26695d9900123d3
IEDL.DBID DOA
ISSN 0030-9982
IngestDate Tue Oct 22 15:15:18 EDT 2024
Fri Oct 25 01:54:25 EDT 2024
Fri Aug 23 02:54:58 EDT 2024
Wed Oct 16 00:38:45 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords Interleukin-6, Interleukin-10, Procalcitonin, Fibrin fragment D, COVID-19, Luminescence, Interleukin-2, Immunoassay, Fibrinogen, Ferritins
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c363t-a36dedfce9f3d5a0e0c8f90769d577ed67dbb9fad593bef47c26695d9900123d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/29214b2b5ad64f219569df43a8545b41
PMID 37482854
PQID 2841402396
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_29214b2b5ad64f219569df43a8545b41
proquest_miscellaneous_2841402396
crossref_primary_10_47391_JPMA_EGY_S4_36
pubmed_primary_37482854
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Pakistan
PublicationPlace_xml – name: Pakistan
PublicationTitle Journal of the Pakistan Medical Association
PublicationTitleAlternate J Pak Med Assoc
PublicationYear 2023
Publisher Pakistan Medical Association
Publisher_xml – name: Pakistan Medical Association
SSID ssj0026500
Score 2.3362918
Snippet To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus...
Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe...
ObjectivesTo investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe...
SourceID doaj
proquest
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage S179
SubjectTerms COVID-19
Fibrin fragment D
Interleukin-10
Interleukin-6
Luminescence
Procalcitonin
Title Relation Between Interleukin-6, Interleukin-10 And Interleukin-2 Receptor And Mortality In Severely Ill COVID-19 Patients
URI https://www.ncbi.nlm.nih.gov/pubmed/37482854
https://search.proquest.com/docview/2841402396
https://doaj.org/article/29214b2b5ad64f219569df43a8545b41
Volume 73(Suppl 4)
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSsQwFA3iQtyIb8cXEVy4MNo2aTJZ-n7AqDAq4yokzS0MjlV0ZuHfe5N2fCzEjZtCm0LCzS3nnObmhJBtKxzOq-TMqgyYUBaYRSLBpLSIfpAAh7B3uHMlz-_EZS_vfTvqK9SE1fbAdeD2M52lwmUut16KMgvb27QvBbdtxH4nauGT6LGYaqQW8o7GkDFhKCiy2tRHKK7T_cubzsHeydkD6woWnZm_8Cja9v_ONSPmnM6SmYYs0oN6kHNkAqp5MtVplsMXyPu4lI025VY0_uAbwOixXzG5--M2Tait_I9HGUXWCC8ou2PTU6TiSMtpv6JdwCSHwTu9GAzo0fX9xTFLNW1sWN8Wyd3pye3ROWvOUmAFl3zILJcefFmALrnPbQJJ0S5RGGMwc6XAS-Wd06X1ueYOSqEKRG6dewSrwLo8XyKT1XMFK4TaBJuD0x8HL6TVzrWVT3OVgi504ZIW2RlH1LzUlhkGpUYMvgnBNxh80xWGyxY5DBH_fC14XccHmAGmyQDzVwa0yNZ4vgx-G2HBw1bwPHozCL2oHzOusaPleiI_uwq2O2H36Op_DGGNTIdj6OuKnnUyOXwdwQaSlaHbjHmJ17Ne-gGYXeR5
link.rule.ids 315,783,787,867,2109,27936,27937
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relation+between+Interleukin-6%2C+Interleukin-10+and+Interleukin-2+Receptor+and+mortality+in+Severely+Ill+COVID-19+patients&rft.jtitle=Journal+of+the+Pakistan+Medical+Association&rft.au=Asmaa+Embarak+Hassan&rft.au=Nahla+Abdelaziz+Nosair&rft.au=Mohammed+Hussien+Ahmed&rft.au=Dalia+Elsayed+Sherif&rft.date=2023-04-01&rft.issn=0030-9982&rft.volume=73&rft.issue=4&rft.spage=S179&rft.epage=S183&rft_id=info:doi/10.47391%2FJPMA.EGY-S4-36&rft.externalDBID=n%2Fa&rft.externalDocID=10_47391_JPMA_EGY_S4_36
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0030-9982&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0030-9982&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0030-9982&client=summon